info-atbvac > Moxifloxacin

Moxifloxacin

Mycoplasma genitalium infection: efficacy of resistance-guided antimicrobial therapy using doxycycline-moxifloxacin and doxycycline-2.5g azithromycin. ( Duygu Durukan et al. )

Resistance-guided antimicrobial therapy using doxycycline-moxifloxacin and doxycycline-2.5g azithromycin for the treatment of Mycoplasma genitalium infection: efficacy and tolerability.
| Dr Jean-Pierre Bru

Mycoplasma genitalium (MG) is highly prone to developing antimicrobial resistance. Macrolide-resistance exceeds 50% in many regions and quinolone-resistance is increasing. … Suite  

Lefamulin versus moxifloxacin for the treatment of community-acquired bacterial pneumonia. Results of a phase III trial. ( File TM. et al. )

Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial.
| Dr Jean-Pierre Bru

Lefamulin is a pleuromutilin antibiotic. Its name comes from the pleuromutilin-producing fungus Pleurotus mutilus. Previous pleuromutilin are already used : … Suite  

Treatment of Mycoplasma genitalium infection: efficacy of a resistance-guided strategy using doxycycline-moxifloxacin or doxycycline-azithromycin. ( Durukan D. et al. )

Resistance-guided antimicrobial therapy using doxycycline-moxifloxacin and doxycycline-2.5g azithromycin for the treatment of Mycoplasma genitalium infection: efficacy and tolerability.
| Dr Jean-Pierre Bru

Macrolide-resistance in Mycoplasma genitalium (MG) exceeds 50% in many regions and quinolone-resistance is increasing. The aim of the study was … Suite